Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04157673 · ClinicalTrials.gov registry record · NA
Imagine to Remember: Improving Medication Adherence in Pre- and Type 2 Diabetes
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04157673: Completed NA study, sponsored by State University of New York at Buffalo.
NCT04157673 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04157673, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Determine if an intervention consisting of future-thinking improves different facets of memory/executive function and/or decision-making.
Primary Outcome
The investigators will measure medication adherence using a medication event monitoring system (MEMS) that measured the frequency and time the medication bottle is opened. Percent adherence was calculated \[(Quantity of pills dispensed - remaining)/(quantity prescribed per day\*days since last refill)\] \*100. Percent change was calculated from the last week of baseline to the first week of EFT and the last week of EFT
Interventions
- BEHAVIORAL Episodic Future Thinking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-08-01 |
| Phase | NA |
What the finished NCT04157673 record still lists
NCT04157673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Episodic Future Thinking is the first listed.
NCT04157673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04157673 about?
NCT04157673 is a clinical study titled "Imagine to Remember: Improving Medication Adherence in Pre- and Type 2 Diabetes". Determine if an intervention consisting of future-thinking improves different facets of memory/executive function and/or decision-making.
What is the current status of trial NCT04157673?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2019-09-01. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT04157673?
The interventions under investigation include: Episodic Future Thinking (BEHAVIORAL).
Who is sponsoring clinical trial NCT04157673?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04157673's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI